Chewy Inc vs iShares Global Tech ETF — how do they compare? Chewy Inc trades at $21.22 (market cap $8.33B), while iShares Global Tech ETF trades at $136.92. The key difference: iShares Global Tech ETF is trading nearer its 52-week high, Chewy Inc nearer its low. Which is the better fit depends on your goals.
| CHWY | IXN | |
|---|---|---|
Market Cap | $8.33B | — |
Sector | Consumer Cyclical | Sector/Thematic |
52-Week High | $42.33 | $149.74 |
52-Week Low | $17.51 | $94.04 |
Enterprise Value | $8.30B | — |
Signals from Pluang's Aura AI — not financial advice
Chewy (CHWY) trades at $20.32, down 2.68% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported $11.86B revenue for 2025 with net income of $392.74M, showing improved profitability. Recent news highlights expansion in pet healthcare and AI-driven operational efficiency, though Q1 2026 earnings missed expectations.
The outlook is mixed: strong analyst consensus (81.58% buy ratings) and a $34.92 price target suggest upside, but near-term risks include consumer trade-down pressures and competitive threats. Long-term growth drivers in pet care and margin expansion offer potential, yet macroeconomic headwinds and execution risks warrant caution.
IXN trades at $136.67, down 2.88% over the past day, with a bullish technical signal from moving averages but neutral oscillators. The ETF offers concentrated exposure to global technology leaders, though financial ratios are not provided in the current dataset. A dividend of $0.17 is scheduled for payment on June 18, 2026.
Outlook is mixed; strong tech sector positioning supports growth potential, but high valuations and concentration risks warrant caution. Key catalysts include AI-driven earnings growth, while risks involve market volatility and stretched expectations. Investors should weigh entry points carefully amid current sentiment.
Trailing returns across standard periods
Latest headlines on both assets
Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Read more on CHWY →IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.
Read more on IXN →